Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 5:11 PM View:  | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 20-Nov-24 | Option Sale | 72,500 | $21.29 | $1,543,530.00 | (2%) 4.55M to 4.48M | |
| Yesterday 5:11 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 20-Nov-24 | Option Exercise | 72,500 | $3.54 | $256,650.00 | 2% 4.48M to 4.55M | |
| Yesterday 5:11 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 19-Nov-24 | Option Exercise | 98,345 | $3.54 | $348,141.00 | 2% 4.48M to 4.58M | |
| Yesterday 5:11 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 19-Nov-24 | Option Sale | 98,345 | $21.19 | $2,083,730.00 | (2%) 4.58M to 4.48M | |
| 15-Nov-24 5:00 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 14-Nov-24 | Option Exercise | 44,655 | $3.54 | $158,079.00 | < 1% 4.48M to 4.52M | |
| 15-Nov-24 5:00 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 14-Nov-24 | Option Sale | 44,655 | $21.75 | $971,336.00 | (< 1%) 4.52M to 4.48M | |
| 15-Nov-24 5:00 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 13-Nov-24 | Option Sale | 92,500 | $22.98 | $2,125,460.00 | (2%) 4.57M to 4.48M | |
| 15-Nov-24 5:00 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 13-Nov-24 | Option Exercise | 92,500 | $3.54 | $327,450.00 | 2% 4.48M to 4.57M | |
| 26-Aug-24 5:00 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 22-Aug-24 | Gift | 5,100 | -- | -- | (< 1%) 4.48M to 4.48M | |
| 23-Aug-24 5:00 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 21-Aug-24 | Option Sale | 15,000 | $20.10 | $301,455.00 | (4%) 363.87K to 348.87K | |
| 23-Aug-24 5:00 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 21-Aug-24 | Option Exercise | 15,000 | $4.01 | $60,150.00 | 4% 348.87K to 363.87K | |
| 22-Aug-24 5:00 PM View: | Miller Steve Chief Op. & Scientific Officer | Catalyst Pharmaceutical Par... (CPRX) | 20-Aug-24 | Private Sale | 150,000 | $20.35 | $3,052,900.00 | (18%) 825.12K to 675.12K | |
| 19-Aug-24 5:00 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Aug-24 | Gift | 45,000 | -- | -- | (< 1%) 4.53M to 4.48M | |
| 13-Aug-24 5:01 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 09-Aug-24 | Option Sale | 100,000 | $18.04 | $1,804,000.00 | (66%) 151.39K to 51.39K | |
| 13-Aug-24 5:01 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 09-Aug-24 | Option Exercise | 100,000 | $4.01 | $401,000.00 | 195% 51.39K to 151.39K | |
| 13-Aug-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 09-Aug-24 | Option Sale | 30,000 | $18.42 | $552,701.00 | (62%) 48.43K to 18.43K | |
| 13-Aug-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 09-Aug-24 | Option Exercise | 30,000 | $2.86 | $85,800.00 | 163% 18.43K to 48.43K | |
| 13-Aug-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 09-Aug-24 | Sale | 6,058 | $18.42 | $111,609.00 | (33%) 18.43K to 12.37K | |
| 11-Jun-24 5:00 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 07-Jun-24 | Private Sale | 7,541 | $16.07 | $121,184.00 | (29%) 25.97K to 18.43K | |
| 07-Jun-24 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 05-Jun-24 | Option Exercise | 80,000 | $4.01 | $320,800.00 | 156% 51.39K to 131.39K | |
| 07-Jun-24 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 05-Jun-24 | Option Sale | 80,000 | $16.16 | $1,292,800.00 | (61%) 131.39K to 51.39K | |
| 05-Jun-24 5:00 PM View: | Daly Richard J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 04-Jun-24 | Option Sale | 17,323 | $15.98 | $276,735.00 | (7%) 252.15K to 234.82K | |
| 05-Jun-24 5:00 PM View: | Daly Richard J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 04-Jun-24 | Option Exercise | 40,000 | $4.01 | $160,400.00 | 19% 212.15K to 252.15K | |
| 05-Jun-24 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 03-Jun-24 | Private Sale | 5,333 | $16.30 | $86,949.20 | (100%) 5.33K to 0 | |
| 10-Apr-24 5:15 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 08-Apr-24 | Option Sale | 25,000 | $15.68 | $392,000.00 | (7%) 373.87K to 348.87K | |
| 10-Apr-24 5:15 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 08-Apr-24 | Option Exercise | 25,000 | $4.01 | $100,250.00 | 7% 348.87K to 373.87K | |
| 28-Mar-24 4:45 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Mar-24 | Private Sale | 25,000 | $16.44 | $411,000.00 | (17%) 149.43K to 124.43K | |
| 16-Feb-24 5:00 PM View: | Sundaram Preethi Chief Strategy Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 6,025 | -- | -- | (19%) 31.57K to 25.54K | |
| 16-Feb-24 5:01 PM View: | Daly Richard J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 1,186 | -- | -- | (< 1%) 213.33K to 212.15K | |
| 16-Feb-24 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 300% 1.33K to 5.33K | |
| 16-Feb-24 5:01 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 1% 344.87K to 348.87K | |
| 16-Feb-24 5:01 PM View: | Denkhaus Donald A Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | < 1% 434.33K to 438.33K | |
| 16-Feb-24 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 2,435 | -- | -- | (5%) 53.83K to 51.39K | |
| 16-Feb-24 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 10,000 | -- | -- | 23% 43.83K to 53.83K | |
| 16-Feb-24 5:01 PM View: | Daly Richard J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 2% 209.33K to 213.33K | |
| 16-Feb-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 10,667 | -- | -- | 58% 18.43K to 29.09K | |
| 16-Feb-24 5:00 PM View: | O'Keeffe Charles B Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | < 1% 681.72K to 685.72K | |
| 16-Feb-24 5:00 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 9,667 | -- | -- | 7% 142.12K to 151.79K | |
| 16-Feb-24 5:00 PM View: | Sundaram Preethi Chief Strategy Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 16,667 | -- | -- | 112% 14.9K to 31.57K | |
| 16-Feb-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 3,125 | -- | -- | (11%) 29.09K to 25.97K | |
| 16-Feb-24 5:00 PM View: | Miller Steve Chief Op. & Scientific Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 13,667 | -- | -- | 2% 811.46K to 825.12K | |
| 16-Feb-24 5:00 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 2,353 | -- | -- | (2%) 151.79K to 149.43K | |
| 06-Feb-24 5:00 PM View: | Denkhaus Donald A Director | Catalyst Pharmaceutical Par... (CPRX) | 05-Feb-24 | Option Exercise | 40,000 | $4.01 | $160,400.00 | 10% 394.33K to 434.33K | |
| 31-Jan-24 5:01 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 30-Jan-24 | Option Exercise | 143,000 | -- | -- | 3% 4.39M to 4.53M | |
| 03-Jan-24 5:18 PM View: | O'Keeffe Charles B Director | Catalyst Pharmaceutical Par... (CPRX) | 02-Jan-24 | Option Exercise | 60,000 | $1.13 | $67,800.00 | 10% 621.72K to 681.72K | |
| 03-Jan-24 5:19 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 02-Jan-24 | Option Exercise | 250,000 | $1.13 | $282,500.00 | 6% 4.14M to 4.39M | |
| 03-Jan-24 5:19 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 02-Jan-24 | Option Exercise | 10,000 | $1.13 | $11,300.00 | 3% 334.87K to 344.87K | |
| 29-Dec-23 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 9,000 | -- | -- | 23% 38.37K to 47.37K | |
| 29-Dec-23 5:00 PM View: | Grande Alicia VP, Treasurer and CFO | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 3,410 | -- | -- | (6%) 59.22K to 55.81K | |
| 29-Dec-23 5:00 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 8,666 | -- | -- | 64% 13.6K to 22.27K |
